Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: Comparison of an extracellular and an SPIO contrast agent

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 1, 2008, Pages 263-270

  Bangard, Christopher ^a   Stippel, Dirk L ^a   Berg, Frank ^a   Kasper, Hans U ^b   Hellmich, Martin ^a   Fischer, Jürgen H ^a   Hölscher, Arnulf ^a   Lackner, Klaus ^a   Gossmann, Axel ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Clemenshospital Munster   (Germany)

Author keywords

Contrast to noise ratio; Magnetic resonance imaging; Porcine liver; Radiofrequency ablation; Superparamagnetic iron oxide (SPIO)

Indexed keywords

FERUCARBOTRAN; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; IRON; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTRAST ENHANCEMENT; DOMESTIC PIG; HISTOPATHOLOGY; LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SIGNAL NOISE RATIO;

ANIMALS; CATHETER ABLATION; CONTRAST MEDIA; GADOLINIUM DTPA; IMAGE ENHANCEMENT; IRON; LIVER; MAGNETIC RESONANCE IMAGING; OXIDES; SWINE;

EID: 46849098401     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21423     Document Type: Article

References (17)

1. Elias D, Baton O, Sideris L, Matsuhisa T, Pocard M, Lasser P. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 2004;11:500-505.
2. Lencioni R, Crocetti L, Cioni D, Della Pina C, Bartolozzi C. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 2004;39:689-697.
3. Goldberg SN. Science to practice: can we differentiate residual untreated tumor from tissue responses to heat following thermal tumor ablation? Radiology 2005;234:317-318.
4. Kim TJ, Moon WK, Cha JH, et al. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor. Radiology 2005;234:423-430.
5. Ni Y, Chen F, Mulier S, et al. Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent. Eur Radiol 2006;16:1031-1040.
6. Lazebnik RS, Weinberg BD, Breen MS, Lewin JS, Wilson DL. Subacute changes in lesion conspicuity and geometry following MR-guided radiofrequency ablation. J Magn Reson Imaging 2003;18:353-359.
7. Lee JD, Lee JM, Kim SW, Kim CS, Mun WS. MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol 2001;2:151-158.
8. Merkle EM, Boll DT, Boaz T, et al. MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: demonstration of feasibility at 0.2 T. Magn Reson Med 1999;42:141-149.
9. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002;223:255-262.
10. Aschoff AJ, Rafie N, Jesberger JA, Duerk JL, Lewin JS. Thermal lesion conspicuity following interstitial radiofrequency thermal tumor ablation in humans: a comparison of STIR, turbo spin-echo T2-weighted, and contrast-enhanced T1-weighted MR images at 0.2 T. J Magn Reson Imaging 2000;12:584-589.
11. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-158.
12. Stroszczynski C, Gaffke G, Gretschel S, et al. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Rofo 2003;175:1368-1375.
13. Donner A, Birkett N, Buck C. Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol 1981;114:906-914.
14. Gonen M, Panageas KS, Larson SM. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology 2001;221:763-767.
15. Reimer P, Muller M, Marx C, et al. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration - preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology 1998;209:831-836.
16. Hori M, Murakami T, Kim T, et al. Hemodynamic characterization of focal hepatic lesions: role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo-planar sequence. J Magn Reson Imaging 2006;23:509-519.
17. Schnorr J, Wagner S, Abramjuk C, et al. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits. Radiology 2006;240:90-100.